Insider Transactions in Q2 2021 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2021
|
Daniel B Soland |
BUY
Exercise of conversion of derivative security
|
Direct |
3,059
+18.98%
|
-
|
|
Jun 22
2021
|
Edmund Harrigan |
BUY
Exercise of conversion of derivative security
|
Direct |
3,059
+42.98%
|
-
|
|
Jun 22
2021
|
Laura Brege |
BUY
Exercise of conversion of derivative security
|
Direct |
3,059
+50.0%
|
-
|
|
Jun 22
2021
|
James M Daly |
BUY
Exercise of conversion of derivative security
|
Direct |
3,059
+50.0%
|
-
|
|
Jun 22
2021
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
25,564
+0.2%
|
-
|
|
Apr 30
2021
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
7,850
-13.73%
|
$157,000
$20.33 P/Share
|
|
Apr 30
2021
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
4,230
-10.4%
|
$84,600
$20.33 P/Share
|
|
Apr 30
2021
|
Austin D. Kim EVP,General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
1,054
-8.48%
|
$21,080
$20.33 P/Share
|
|
Apr 30
2021
|
Elena Ridloff EVP and CFO |
SELL
Open market or private sale
|
Direct |
1,032
-8.91%
|
$20,640
$20.33 P/Share
|
|
Apr 29
2021
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+21.47%
|
-
|
|
Apr 29
2021
|
Srdjan R. Stankovic President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,615
+19.12%
|
-
|
|
Apr 29
2021
|
Austin D. Kim EVP,General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,005
+19.48%
|
-
|
|
Apr 29
2021
|
Elena Ridloff EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,245
+21.88%
|
-
|